Zhejiang Taimei Medical Technology Co., Ltd.
Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders; PharmaOS, a pharmaceutical digital marketing platform; and Ente… Read more
Zhejiang Taimei Medical Technology Co., Ltd. (A2V) - Total Assets
Latest total assets as of June 2025: €1.52 Billion EUR
Based on the latest financial reports, Zhejiang Taimei Medical Technology Co., Ltd. (A2V) holds total assets worth €1.52 Billion EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Zhejiang Taimei Medical Technology Co., Ltd. - Total Assets Trend (2021–2024)
This chart illustrates how Zhejiang Taimei Medical Technology Co., Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Zhejiang Taimei Medical Technology Co., Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Zhejiang Taimei Medical Technology Co., Ltd.'s total assets of €1.52 Billion consist of 93.3% current assets and 6.7% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 20.2% |
| Accounts Receivable | €168.06 Million | 10.6% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €21.17 Million | 1.3% |
| Goodwill | €37.01 Million | 2.3% |
Asset Composition Trend (2021–2024)
This chart illustrates how Zhejiang Taimei Medical Technology Co., Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang Taimei Medical Technology Co., Ltd.'s current assets represent 93.3% of total assets in 2024, an increase from 88.2% in 2021.
- Cash Position: Cash and equivalents constituted 20.2% of total assets in 2024, down from 37.6% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 5.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 10.6% of total assets.
Zhejiang Taimei Medical Technology Co., Ltd. Competitors by Total Assets
Key competitors of Zhejiang Taimei Medical Technology Co., Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
UCrest Bhd
KLSE:0005
|
Malaysia | RM48.46 Million |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
China | CN¥265.74 Million |
|
BIT Computer Co. Ltd
KQ:032850
|
Korea | ₩82.38 Billion |
|
ezCaretech Co. LTD
KQ:099750
|
Korea | ₩56.71 Billion |
|
SyntekaBio Inc
KQ:226330
|
Korea | ₩33.49 Billion |
|
Carelabs Co.Ltd
KQ:263700
|
Korea | ₩105.15 Billion |
|
Shanghai Kingstar Winning Software
SHE:300253
|
China | CN¥8.35 Billion |
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.33 Billion |
Zhejiang Taimei Medical Technology Co., Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Zhejiang Taimei Medical Technology Co., Ltd. generates 0.35x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Zhejiang Taimei Medical Technology Co., Ltd. is currently not profitable relative to its asset base.
Zhejiang Taimei Medical Technology Co., Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.66 | - | - |
| Quick Ratio | 5.66 | - | - |
| Cash Ratio | 0.00 | - | - |
| Working Capital | €1.17 Billion | - | - |
Zhejiang Taimei Medical Technology Co., Ltd. - Advanced Valuation Insights
This section examines the relationship between Zhejiang Taimei Medical Technology Co., Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.71 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 9.6% |
| Total Assets | €1.58 Billion |
| Market Capitalization | $47.71 Million USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang Taimei Medical Technology Co., Ltd.'s assets below their book value (0.03 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Zhejiang Taimei Medical Technology Co., Ltd.'s assets grew by 9.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Zhejiang Taimei Medical Technology Co., Ltd. (2021–2024)
The table below shows the annual total assets of Zhejiang Taimei Medical Technology Co., Ltd. from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €1.58 Billion | +9.59% |
| 2023-12-31 | €1.44 Billion | -20.85% |
| 2022-12-31 | €1.83 Billion | +1.14% |
| 2021-12-31 | €1.80 Billion | -- |